(Q46344305)

21 December 2017

title

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis (English)

1 reference

21 December 2017

0 references

Alberto Ortiz

6

0 references

author name string

Pieter Evenepoel

1

1 reference

21 December 2017

Rafael Selgas

2

1 reference

21 December 2017

Flavia Caputo

3

1 reference

21 December 2017

Lukas Foggensteiner

4

1 reference

21 December 2017

James G Heaf

5

1 reference

21 December 2017

Alison Kelly

7

1 reference

21 December 2017

Scott Chasan-Taber

8

1 reference

21 December 2017

Ajay Duggal

9

1 reference

21 December 2017

Stanley Fan

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 September 2008

1 reference

21 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

21 December 2017

volume

24

1 reference

21 December 2017

page(s)

278-285

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Coronary artery calcification, systemic inflammation markers and mineral metabolism in a peritoneal dialysis population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Dynamic analysis of peritoneal dialysis associated peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Arterial calcifications and bone histomorphometry in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Sevelamer hydrochloride: an effective phosphate binder in dialyzed children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

The importance of residual renal function in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN488

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN488

1 reference

21 December 2017

PubMed ID

18820280

1 reference

21 December 2017